Chang, M. C., Souter, L. H., Kamel-Reid, S., Rutherford, M., Bedard, P., Trudeau, M., . . . Eisen, A. (2017). Clinical utility of multigene profiling assays in early-stage breast cancer. Current Oncology, 24(5), e403. https://doi.org/10.3747/co.24.3595
Chicago Style (17th ed.) CitationChang, M. C., L. H. Souter, S. Kamel-Reid, M. Rutherford, P. Bedard, M. Trudeau, J. Hart, and A. Eisen. "Clinical Utility of Multigene Profiling Assays in Early-stage Breast Cancer." Current Oncology 24, no. 5 (2017): e403. https://doi.org/10.3747/co.24.3595.
MLA (9th ed.) CitationChang, M. C., et al. "Clinical Utility of Multigene Profiling Assays in Early-stage Breast Cancer." Current Oncology, vol. 24, no. 5, 2017, p. e403, https://doi.org/10.3747/co.24.3595.